Total Payments
$3,636
2024 Payments
$1,746
Companies
18
Transactions
99
Medicare Patients
2,977
Medicare Billing
$198,904
Payment Breakdown by Category
Food & Beverage$2,756 (75.8%)
Consulting$800.00 (22.0%)
Education$80.09 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,756 | 96 | 75.8% |
| Consulting Fee | $800.00 | 1 | 22.0% |
| Education | $80.09 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho Dermatologics, a division of Bausch Health US, LLC | $827.16 | 3 | $0 (2024) |
| ABBVIE INC. | $580.90 | 28 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $384.81 | 3 | $0 (2022) |
| Lilly USA, LLC | $324.56 | 14 | $0 (2024) |
| PFIZER INC. | $296.52 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $281.61 | 14 | $0 (2024) |
| GENZYME CORPORATION | $244.64 | 4 | $0 (2024) |
| Dermavant Sciences, Inc. | $240.41 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $120.85 | 5 | $0 (2024) |
| Amgen Inc. | $63.98 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,746 | 41 | Ortho Dermatologics, a division of Bausch Health US, LLC ($827.16) |
| 2023 | $1,429 | 50 | ABBVIE INC. ($389.35) |
| 2022 | $460.94 | 8 | Janssen Scientific Affairs, LLC ($384.81) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.48 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $25.65 | General |
| 11/25/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Podiatry | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $32.22 | General |
| Category: DERMATOLOGY | ||||||
| 09/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Immunology | ||||||
| 08/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DERMATOLOGY | ||||||
| 08/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 06/22/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Dermatology | ||||||
| 06/22/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Dermatology | ||||||
| 06/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $53.66 | General |
| Category: DERMATOLOGY | ||||||
| 06/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,644 | 4,828 | $491,866 | $180,756 |
| 2022 | 8 | 333 | 457 | $43,470 | $18,148 |
Total Patients
2,977
Total Services
5,285
Medicare Billing
$198,904
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 765 | 1,183 | $148,065 | $62,183 | 42.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 335 | 443 | $84,170 | $32,251 | 38.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 481 | 677 | $71,085 | $21,024 | 29.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 260 | 315 | $56,510 | $17,092 | 30.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 37 | 46 | $20,884 | $9,765 | 46.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 145 | 145 | $25,375 | $9,036 | 35.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 320 | 1,680 | $16,800 | $7,802 | 46.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 38 | 46 | $12,880 | $5,281 | 41.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 33 | 38 | $21,080 | $3,385 | 16.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 69 | 88 | $8,320 | $3,114 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 31 | $6,240 | $2,804 | 44.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 77 | $6,930 | $2,465 | 35.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $6,512 | $2,018 | 31.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $2,395 | $1,146 | 47.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,700 | $825.76 | 30.6% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 11 | 12 | $1,920 | $565.08 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 107 | $13,375 | $6,709 | 50.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 49 | 49 | $8,330 | $3,021 | 36.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 32 | 34 | $6,460 | $2,791 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 64 | 66 | $6,930 | $2,146 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,150 | $1,137 | 36.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 18 | 25 | $2,125 | $897.28 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $1,710 | $758.48 | 44.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 41 | 139 | $1,390 | $687.73 | 49.5% |
About Kendall Johnson, PA-C
Kendall Johnson, PA-C is a Physician Assistant healthcare provider based in Cameron Park, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2022. The National Provider Identifier (NPI) number assigned to this provider is 1760118160.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kendall Johnson, PA-C has received a total of $3,636 in payments from pharmaceutical and medical device companies, with $1,746 received in 2024. These payments were reported across 99 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,756).
As a Medicare-enrolled provider, Johnson has provided services to 2,977 Medicare beneficiaries, totaling 5,285 services with total Medicare billing of $198,904. Data is available for 2 years (2022–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Cameron Park, CA
- Active Since 07/27/2022
- Last Updated 07/27/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1760118160
Products in Payments
- Cabtreo (Drug) $807.53
- TREMFYA (Drug) $621.02
- DUPIXENT (Biological) $365.49
- TALTZ (Drug) $324.56
- SKYRIZI (Biological) $317.16
- RINVOQ (Biological) $249.97
- VTAMA (Drug) $240.41
- CIBINQO (Drug) $127.30
- LITFULO (Drug) $122.31
- Otezla (Drug) $63.98
- Sotyktu (Drug) $58.39
- AREXVY (Drug) $48.98
- EUCRISA (Drug) $46.91
- AMELUZ (Drug) $32.22
- Cimzia (Drug) $29.00
- ILUMYA (Biological) $25.15
- REMICADE (Biological) $24.18
- SIMPONI ARIA (Biological) $21.22
- Winlevi (Drug) $19.78
- JUBLIA (Drug) $19.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.